Prurigo Nodularis clinical trials at University of California Health

1 research study open to eligible people

Barzolvolimab in Patients With Prurigo Nodularis
open to eligible people ages 18 years and up
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.
at UCSF

Last updated: October 24, 2025